These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8125159)

  • 21. Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by rasV12 mutated protein and the E1A oncogene.
    Vasseur S; Malicet C; Calvo EL; Labrie C; Berthezene P; Dagorn JC; Iovanna JL
    Mol Cancer; 2003 Mar; 2():19. PubMed ID: 12685932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequent activation of non-ras transforming sequences in neoplastic Syrian hamster cells initiated with chemical carcinogens.
    Notario V; Castro R; Flessate DM; Doniger J; DiPaolo JA
    Oncogene; 1990 Sep; 5(9):1425-30. PubMed ID: 2216466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transforming growth factor beta 1 selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed fibrosarcoma cell lines.
    Hurta RA; Greenberg AH; Wright JA
    J Cell Physiol; 1993 Aug; 156(2):272-9. PubMed ID: 8344985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible involvement of the inactivation of the Rho-Rho-kinase pathway in oncogenic Ras-induced transformation.
    Izawa I; Amano M; Chihara K; Yamamoto T; Kaibuchi K
    Oncogene; 1998 Dec; 17(22):2863-71. PubMed ID: 9879992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells.
    Schedin PJ; Eckel-Mahan KL; McDaniel SM; Prescott JD; Brodsky KS; Tentler JJ; Gutierrez-Hartmann A
    Oncogene; 2004 Mar; 23(9):1766-79. PubMed ID: 14767472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncogenic Ras-mediated downregulation of Gadd153/CHOP is required for Ras-induced cellular transformation.
    Rong R; Montalbano J; Jin W; Zhang J; Garling M; Sheikh MS; Huang Y
    Oncogene; 2005 Jul; 24(30):4867-72. PubMed ID: 15870698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligand-independent regulation of ErbB4 receptor phosphorylation by activated Ras.
    Tal-Or P; Erlich S; Porat-Shliom N; Goldshmit Y; Ben-Baruch G; Shaharabani E; Kloog Y; Pinkas-Kramarski R
    J Cell Biochem; 2006 Aug; 98(6):1482-94. PubMed ID: 16518842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
    Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
    J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant transformation of an infinite life span human fibroblast cell strain by transfection with v-Ki-ras.
    Fry DG; Milam LD; Dillberger JE; Maher VM; McCormick JJ
    Oncogene; 1990 Sep; 5(9):1415-8. PubMed ID: 2216465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucocorticoid dexamethasone reversibly complements EJ-RAS oncogene to transform mouse embryo BALB-3T3 cells.
    Kovary K; Armelin MC; Armelin HA
    J Cell Biochem; 1989 Dec; 41(4):171-7. PubMed ID: 2696739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation by normal serum factors of Kirsten murine sarcoma virus-induced transformation in adult rat cells infected in early passage.
    Auersperg N; Siemens CH; Krystal G; Myrdal SE
    Cancer Res; 1986 Nov; 46(11):5715-23. PubMed ID: 3019533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid cell transformation requires the expression of the HMGA1 proteins.
    Berlingieri MT; Pierantoni GM; Giancotti V; Santoro M; Fusco A
    Oncogene; 2002 May; 21(19):2971-80. PubMed ID: 12082527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphological transformation, focus formation, and anchorage independence induced in diploid human fibroblasts by expression of a transfected H-ras oncogene.
    Hurlin PJ; Fry DG; Maher VM; McCormick JJ
    Cancer Res; 1987 Nov; 47(21):5752-7. PubMed ID: 2444334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
    Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
    Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dexamethasone-dependent inhibition of differentiation of C2 myoblasts bearing steroid-inducible N-ras oncogenes.
    Gossett LA; Zhang W; Olson EN
    J Cell Biol; 1988 Jun; 106(6):2127-37. PubMed ID: 3133379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible involvement of two signaling pathways in induction of neuron-associated properties by v-Ha-ras gene in PC12 cells.
    Sugimoto Y; Noda M; Kitayama H; Ikawa Y
    J Biol Chem; 1988 Aug; 263(24):12102-8. PubMed ID: 2841343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance to oncogenic transformation in revertant R1 of human ras-transformed NIH 3T3 cells.
    Kuzumaki N; Ogiso Y; Oda A; Fujita H; Suzuki H; Sato C; Müllauer L
    Mol Cell Biol; 1989 May; 9(5):2258-63. PubMed ID: 2664473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Keratin expression and steroidogenesis in rat granulosa cells, transformed with the Kirsten-ras and SV40 oncogenes singly and in combination.
    Pan J; Kwan RW; Auersperg N
    Mol Cell Endocrinol; 1995 Aug; 112(2):231-9. PubMed ID: 7489827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional expression of dihydropyridine-insensitive calcium channels during PC12 cell differentiation by nerve growth factor (NGF), oncogenic ras, or src tyrosine kinase.
    Rausch DM; Lewis DL; Barker JL; Eiden LE
    Cell Mol Neurobiol; 1990 Jun; 10(2):237-55. PubMed ID: 2163753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation of a subclonal cell line of PC12 transfected with dexamethasone-regulated ras oncogene: morphological differentiation, biochemical properties, and tumorigenicity.
    Kojima H; Hara K; Mineta-Kitajima R; Taguchi F; Matsutani S; Yamamoto N; Kodate S; Shirataka M; Tamai Y
    J Biochem; 1993 Aug; 114(2):194-202. PubMed ID: 8262899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.